Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 2 | 1 | — | 1 | 4 |
Hyperparathyroidism | D006961 | EFO_0008506 | E21.3 | — | 2 | 1 | — | 1 | 4 |
Secondary hyperparathyroidism | D006962 | EFO_1001173 | — | — | 2 | 1 | — | 1 | 4 |
Chronic renal insufficiency | D051436 | — | N18 | — | 2 | 1 | — | — | 3 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | 2 | 1 | — | — | 3 |
Renal dialysis | D006435 | EFO_0010690 | Z99.2 | — | 1 | 1 | — | — | 2 |
Drug common name | Maxacalcitol |
INN | maxacalcitol |
Description | Maxacalcitol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target vitamin D3 receptor. |
Classification | Small molecule |
Drug class | vitamin D analogs |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O |
PDB | — |
CAS-ID | 103909-75-7 |
RxCUI | — |
ChEMBL ID | CHEMBL333950 |
ChEBI ID | — |
PubChem CID | 12019456 |
DrugBank | — |
UNII ID | N2UJM5NBF6 (ChemIDplus, GSRS) |